A Single Center, Open Label, Fixed Sequence, Two-Period Study to Investigate the Effect of Multiple Dose Valproate on the Pharmacokinetics of Ro4917838 and Vice Versa in Healthy Male Volunteers.

Trial Profile

A Single Center, Open Label, Fixed Sequence, Two-Period Study to Investigate the Effect of Multiple Dose Valproate on the Pharmacokinetics of Ro4917838 and Vice Versa in Healthy Male Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 14 Jun 2016

At a glance

  • Drugs Bitopertin (Primary) ; Valproic acid
  • Indications Epilepsy; Schizophrenia
  • Focus Pharmacokinetics
  • Sponsors Roche
  • Most Recent Events

    • 15 Aug 2012 Actual end date (Jan 2012) added as reported by ClinicalTrials.gov.
    • 06 Jul 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 22 Dec 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top